Amy Armstrong, MD

Pediatric Hematologist/ Oncologist

Primary Academic Title

Assistant Professor of Pediatrics, Division of Hematology and Oncology, Washington University School of Medicine

Clinical Expertise

Pediatric cancers, solid tumors, adolescent and young adult sarcoma, NF-1 related malignancies

Research Interest

Pediatric cancers

Education

2012: MD, Virginia Commonwealth University, Richmond

Training

2012 - 2015: Intern and resident, pediatrics, Northwestern University, Chicago

Board Certification

2015: American Board of Pediatrics
2019: American Board of Pediatrics - hematology and oncology

Selected Research Publications

Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusions.

Desai AV, Bagchi A, Armstrong AE, [...] Fox E
Eur J Cancer 2025

Associations of Patient Age, Tumor Nephrectomy Weight, and Tumor Diameter with Event-Free and Overall Survival in Stage I or II Favorable Histology Wilms Tumor: A Pooled Analysis of Children's Oncology Group Studies AREN0532 and AREN03B2.

Renfro LA, Vallance KL, Tfirn IC, [...] Armstrong AE, [...] Mullen EA
Ann Surg 2025

Treatment of focal anaplastic Wilms tumor: A report from the Children's Oncology Group AREN0321 and AREN03B2 studies.

Armstrong AE, Daw NC, Renfro LA, [...] Dome JS
Cancer 2025

Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.

Sundby RT, Szymanski JJ, Pan AC, [...] Armstrong AE, [...] Shern JF
Clin Cancer Res 2024

Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer.

Zhao Z, Patel PA, Slatnick L, [...] Armstrong A, [...] Esbenshade AJ
J Clin Oncol 2024

Sustained Response with Dose-reduced Selpercatinib in a Pediatric Patient with Metastatic NCOA4-RET Fusion Papillary Thyroid Carcinoma.

Suydam AC, Bach A, Markovina S, [...] Armstrong AE
J Pediatr Hematol Oncol 2023

Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas.

Armstrong AE, Belzberg AJ, Crawford JR, Hirbe AC , Wang ZJ
BMC Cancer 2023

Sclerosing Epithelioid Fibrosarcoma of the Liver in a Pediatric Patient.

Armstrong A, Boulos F, Kulkarni S, [...] He M
Pediatr Dev Pathol 2023

Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).

Desai AV, Robinson GW, Gauvain K, [...] Armstrong AE, [...] Fox E
Neuro-oncology 2022

View All Publications

Contact Information

Siteman Kids at St. Louis Children’s Hospital

1 Children's Place
St. Louis, MO 63110

Phone Numbers

Appointments: (314) 747-7222
Toll Free: (800) 600-3606

Request an appointment